Ardelyx reported $19.73M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US USD 2.83B 98M
Amgen AMGN:US USD 1.47B 181M
Ardelyx ARDX:US USD 19.73M 1.06M
Astrazeneca AZN:US USD 3.53B 174M
Biocept BIOC:US USD 4.02M 1.93M
Chimerix CMRX:US USD 5.35M 34K
Corcept Therapeutics CORT:US USD 42.32M 7.16M
Curis CRIS:US USD 4.33M 226K
Life Technologies LIFE:US USD 3.43M 199K
Opko Health OPK:US USD 74M 5.67M
Tg Therapeutics TGTX:US USD 22.5M 8.25M
United Therapeutics UTHR:US USD 152M 53.6M